Lonza | LONN - La Marge Brute Sur Les Ventes





La Marge Brute Sur Les Ventes Changement Date
Akzo Nobel EUR 1.09B 108M 2026-06
Alcon AG USD 1.68B 16M 2026-06
Almirall EUR 429.87M 180.02M 2025-12
AstraZeneca USD 12.86B 251M 2026-06
BASF EUR 4.33B 181M 2026-06
Bayer EUR 6.33B 1.84B 2026-06
Beiersdorf EUR 1.54B 1.16B 2025-06
Covestro EUR 212M 276M 2025-12
Demant DKK 9.96B 1.13B 2026-06
Fresenius EUR 1.55B 16M 2026-06
Fresenius Medical Care EUR 1.31B 130.98M 2026-06
Geberit CHF 524.3M 125.1M 2025-12
Genmab DKK 1.07B 240M 2026-06
Givaudan CHF 1.55B 140M 2025-12
GlaxoSmithKline GBP 6.51B 757M 2026-06
GN Store Nord DKK 1.13B 116M 2026-06
Hikma Pharmaceutical USD 362.5M 329.5M 2025-06
Johnson Matthey GBP 480M 33M 2024-06
Merck EUR 3.17B 101M 2026-06
Novartis USD 11.24B 1.18B 2026-06
Philips EUR 2.15B 384M 2026-06
Roche Holding CHF 22.69B 600M 2026-06
Sanofi EUR 8.71B 602M 2026-06
Sika AG CHF 3.02B 104.6M 2025-12
Smith & Nephew USD 2.09B 117M 2025-12
Solvay EUR 213M 53M 2026-06
UCB EUR 3.19B 621M 2025-12